Omicron is a variant of COVID-19 that, along with its subvariants, has shown to be more transmissible than previous forms of the virus. As with all other variants of COVID-19, our stance remains that prevention remains the best policy. We strongly encourage the public to get vaccinated and stay up to date on boosters. The original COVID-19 vaccines and boosters have proven to help prevent severe disease, hospitalization, and death during Omicron surges. As of September 2022, bivalent boosters from both Pfizer-BioNTech and Moderna are now authorized – offering broader protection against COVID-19, including the Omicron variant and subvariants. The Pfizer bivalent booster is authorized for those 12 and up, and the Moderna is authorized for ages 18 and up.